Good points Ice.
Re Immuno, it is more accurate to say that StarBright have offered (but still no deal done yet... I really want to know why) to provide $18m for further research in exchange for a share of the immuno rights. AHZ isn't "selling" it for $18 million. It's a subtle but important difference. It won't help the cash issue at all.
I share the view that they need to announce some good news, and a lot of it. I am not sure they actually will though. Who knows. They are burying news in 4cs now and it is all a bit strange to be honest. Twitter dead. No announcements. No communication.
Realistic overtake price, page-61
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.80 | 10 | 2 |
View Market Depth
| Last trade - 16.16pm 22/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable